150 related articles for article (PubMed ID: 19156836)
1. Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
Natrajan R; Lambros MB; Geyer FC; Marchio C; Tan DS; Vatcheva R; Shiu KK; Hungermann D; Rodriguez-Pinilla SM; Palacios J; Ashworth A; Buerger H; Reis-Filho JS
Genes Chromosomes Cancer; 2009 Apr; 48(4):351-65. PubMed ID: 19156836
[TBL] [Abstract][Full Text] [Related]
2. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic and genomic characterization of papillary carcinomas of the breast.
Duprez R; Wilkerson PM; Lacroix-Triki M; Lambros MB; MacKay A; A'Hern R; Gauthier A; Pawar V; Colombo PE; Daley F; Natrajan R; Ward E; MacGrogan G; Arbion F; Michenet P; Weigelt B; Vincent-Salomon A; Reis-Filho JS
J Pathol; 2012 Feb; 226(3):427-441. PubMed ID: 22025283
[TBL] [Abstract][Full Text] [Related]
4. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.
Marchiò C; Iravani M; Natrajan R; Lambros MB; Geyer FC; Savage K; Parry S; Tamber N; Fenwick K; Mackay A; Schmitt FC; Bussolati G; Ellis I; Ashworth A; Sapino A; Reis-Filho JS
J Pathol; 2009 Jul; 218(3):301-15. PubMed ID: 19479727
[TBL] [Abstract][Full Text] [Related]
5. Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer.
Hungermann D; Schmidt H; Natrajan R; Tidow N; Poos K; Reis-Filho JS; Brandt B; Buerger H; Korsching E
J Pathol; 2011 Aug; 224(4):517-28. PubMed ID: 21706489
[TBL] [Abstract][Full Text] [Related]
6. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH.
Roylance R; Gorman P; Papior T; Wan YL; Ives M; Watson JE; Collins C; Wortham N; Langford C; Fiegler H; Carter N; Gillett C; Sasieni P; Pinder S; Hanby A; Tomlinson I
Oncogene; 2006 Oct; 25(49):6544-53. PubMed ID: 16702952
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 16q loss--a genetic key to the understanding of breast carcinogenesis.
Bürger H; de Boer M; van Diest PJ; Korsching E
Histol Histopathol; 2013 Mar; 28(3):311-20. PubMed ID: 23348384
[TBL] [Abstract][Full Text] [Related]
9. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
10. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
11. Absence of microsatellite instability in mucinous carcinomas of the breast.
Lacroix-Triki M; Lambros MB; Geyer FC; Suarez PH; Reis-Filho JS; Weigelt B
Int J Clin Exp Pathol; 2010 Nov; 4(1):22-31. PubMed ID: 21228925
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.
Lopez-Garcia MA; Geyer FC; Natrajan R; Kreike B; Mackay A; Grigoriadis A; Reis-Filho JS; Weigelt B
J Pathol; 2010 Sep; 222(1):64-75. PubMed ID: 20593406
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
[TBL] [Abstract][Full Text] [Related]
14. Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.
Loo LW; Ton C; Wang YW; Grove DI; Bouzek H; Vartanian N; Lin MG; Yuan X; Lawton TL; Daling JR; Malone KE; Li CI; Hsu L; Porter PL
Genes Chromosomes Cancer; 2008 Dec; 47(12):1049-66. PubMed ID: 18720524
[TBL] [Abstract][Full Text] [Related]
15. Patterns of chromosomal imbalances in invasive breast cancer.
Richard F; Pacyna-Gengelbach M; Schlüns K; Fleige B; Winzer KJ; Szymas J; Dietel M; Petersen I; Schwendel A
Int J Cancer; 2000 May; 89(3):305-10. PubMed ID: 10861509
[TBL] [Abstract][Full Text] [Related]
16. BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.
Bane AL; Beck JC; Bleiweiss I; Buys SS; Catalano E; Daly MB; Giles G; Godwin AK; Hibshoosh H; Hopper JL; John EM; Layfield L; Longacre T; Miron A; Senie R; Southey MC; West DW; Whittemore AS; Wu H; Andrulis IL; O'Malley FP
Am J Surg Pathol; 2007 Jan; 31(1):121-8. PubMed ID: 17197928
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling of histological special types of breast cancer.
Horlings HM; Weigelt B; Anderson EM; Lambros MB; Mackay A; Natrajan R; Ng CK; Geyer FC; van de Vijver MJ; Reis-Filho JS
Breast Cancer Res Treat; 2013 Nov; 142(2):257-69. PubMed ID: 24162157
[TBL] [Abstract][Full Text] [Related]
18. Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways.
Roylance R; Gorman P; Hanby A; Tomlinson I
J Pathol; 2002 Jan; 196(1):32-6. PubMed ID: 11748639
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology.
Geyer FC; de Biase D; Lambros MB; Ragazzi M; Lopez-Garcia MA; Natrajan R; Mackay A; Kurelac I; Gasparre G; Ashworth A; Eusebi V; Reis-Filho JS; Tallini G
Breast Cancer Res Treat; 2012 Feb; 132(1):15-28. PubMed ID: 21509527
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
